Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement
Evaluation of Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement Over 12 Weeks
Efforia, Inc
100 participants
Sep 10, 2025
INTERVENTIONAL
Conditions
Summary
This study evaluates changes in hunger perception and body composition-related measures following daily use of a commercially available dietary supplement formulated to support leptin-related metabolic signaling. Adult participants will self-administer the supplement for 12 weeks and complete periodic self-reported assessments related to appetite, hunger, and weight-related outcomes. Participants serve as their own control, with comparisons made between baseline and follow-up measurements. The study is designed to generate preliminary, real-world evidence regarding supplement use in a general wellness context.
Eligibility
Inclusion Criteria4
- Adults aged 18 years or older
- Willing to pay for study supplies and able to take the dietary supplement daily for 12 weeks
- Willing to complete electronic questionnaires and self-reported measurements
- Able to provide informed consent
Exclusion Criteria4
- Pregnant or breastfeeding individuals
- Known allergy or sensitivity to any supplement ingredients
- Use of medications or supplements that could interfere with appetite or weight without medical clearance
- Any medical condition that would make participation unsafe, as determined by the participant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will self-administer the Leptin Balance Formula daily for 12 weeks according to product labeling. The supplement is commercially available and includes African mango seed extract, chromium picolinate, Ceylon cinnamon, and alpha lipoic acid.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07442864